Roberta Catania, Sandra Quinn, Amir A Rahsepar, Tugce Agirlar Trabzonlu, Jay B Bisen, Kelvin Chow, Daniel C Lee, Ryan Avery, Peter Kellman, Bradley D Allen
求助PDF
{"title":"定量应激第一遍灌注心脏MRI:最新进展。","authors":"Roberta Catania, Sandra Quinn, Amir A Rahsepar, Tugce Agirlar Trabzonlu, Jay B Bisen, Kelvin Chow, Daniel C Lee, Ryan Avery, Peter Kellman, Bradley D Allen","doi":"10.1148/rg.240115","DOIUrl":null,"url":null,"abstract":"<p><p>Quantitative stress perfusion (qPerf) cardiac magnetic resonance (CMR) imaging is a noninvasive approach used to quantify myocardial blood flow (MBF). Compared with visual analysis, qPerf CMR has superior diagnostic accuracy in the detection of myocardial ischemia and assessment of ischemic burden. In the evaluation of epicardial coronary artery disease (CAD), qPerf CMR improves the distinction of single-vessel from multivessel disease, yielding a more accurate estimate of the ischemic burden, and in turn improving patient management. In patients with chest pain without epicardial CAD, the findings of lower stress MBF and myocardial perfusion reserve (MPR) allow the diagnosis of microvascular dysfunction (MVD). Given its accuracy, MBF quantification with stress CMR has been introduced into the most recent recommendations for diagnosis in patients who have ischemia with nonobstructive CAD. Recent studies have shown a greater decrease in stress MBF and MPR in patients with three-vessel CAD compared with those in patients with MVD, demonstrating an important role that quantitative stress CMR can play in differentiating these etiologies in patients with stable angina. In cases of hypertrophic cardiomyopathy and cardiac amyloidosis, qPerf CMR aids in early diagnosis of ischemia and in risk assessment. Ischemia also results from alterations in hemodynamics that may occur with valve disease such as aortic stenosis or in cases of heart failure. qPerf CMR has emerged as a useful noninvasive tool for detection of cardiac allograft vasculopathy in patients who have undergone heart transplant. The authors review the basic principles and current primary clinical applications of qPerf CMR. <sup>©</sup>RSNA, 2025 Supplemental material is available for this article. See the invited commentary by Leung and Ng in this issue.</p>","PeriodicalId":54512,"journal":{"name":"Radiographics","volume":"45 3","pages":"e240115"},"PeriodicalIF":5.2000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quantitative Stress First-Pass Perfusion Cardiac MRI: State of the Art.\",\"authors\":\"Roberta Catania, Sandra Quinn, Amir A Rahsepar, Tugce Agirlar Trabzonlu, Jay B Bisen, Kelvin Chow, Daniel C Lee, Ryan Avery, Peter Kellman, Bradley D Allen\",\"doi\":\"10.1148/rg.240115\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Quantitative stress perfusion (qPerf) cardiac magnetic resonance (CMR) imaging is a noninvasive approach used to quantify myocardial blood flow (MBF). Compared with visual analysis, qPerf CMR has superior diagnostic accuracy in the detection of myocardial ischemia and assessment of ischemic burden. In the evaluation of epicardial coronary artery disease (CAD), qPerf CMR improves the distinction of single-vessel from multivessel disease, yielding a more accurate estimate of the ischemic burden, and in turn improving patient management. In patients with chest pain without epicardial CAD, the findings of lower stress MBF and myocardial perfusion reserve (MPR) allow the diagnosis of microvascular dysfunction (MVD). Given its accuracy, MBF quantification with stress CMR has been introduced into the most recent recommendations for diagnosis in patients who have ischemia with nonobstructive CAD. Recent studies have shown a greater decrease in stress MBF and MPR in patients with three-vessel CAD compared with those in patients with MVD, demonstrating an important role that quantitative stress CMR can play in differentiating these etiologies in patients with stable angina. In cases of hypertrophic cardiomyopathy and cardiac amyloidosis, qPerf CMR aids in early diagnosis of ischemia and in risk assessment. Ischemia also results from alterations in hemodynamics that may occur with valve disease such as aortic stenosis or in cases of heart failure. qPerf CMR has emerged as a useful noninvasive tool for detection of cardiac allograft vasculopathy in patients who have undergone heart transplant. The authors review the basic principles and current primary clinical applications of qPerf CMR. <sup>©</sup>RSNA, 2025 Supplemental material is available for this article. See the invited commentary by Leung and Ng in this issue.</p>\",\"PeriodicalId\":54512,\"journal\":{\"name\":\"Radiographics\",\"volume\":\"45 3\",\"pages\":\"e240115\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiographics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1148/rg.240115\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiographics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/rg.240115","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
引用
批量引用